July 14,2006
Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs
Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.
Next Article Previous Article
Recent News
- Working Families Tax Cuts Drive Investment to Local Communities
- Crapo, Wyden, Colleagues Call on Trump to Prioritize Opening Japanese Market Access to U.S. Potato Industry
- Working Families Tax Cuts Celebrate Employees
- Support Grows for Taxpayer Assistance and Service Act
- Working Families Tax Cuts Support the Next Generation